Development and Challenges of the Discovery of HER2 Inhibitors

Area of Science:

• Oncology
• Pharmacology
• Medicinal Chemistry

Background:

• Cancer treatment remains a global challenge, with chemotherapy crucial for inoperable cases.
• Small molecule inhibitors are indispensable in cancer therapy.
• HER2 (Human Epidermal growth factor Receptor 2) inhibitors have significantly advanced cancer treatment.

Purpose of the Study:

• To review the development of HER2 inhibitors.
• To discuss the challenges in the discovery and clinical application of HER2 inhibitors.

Main Methods:

• Literature review of HER2 inhibitor development.
• Analysis of current clinical research and market-approved HER2 inhibitors.
• Examination of resistance mechanisms.

Main Results:

• Several HER2 inhibitors are approved or in clinical trials.
• Ongoing research focuses on novel HER2 inhibitors targeting diverse pathways.
• Acquired resistance to existing HER2 inhibitors poses a major clinical hurdle.

Conclusions:

• HER2 inhibitors have revolutionized cancer therapy, but resistance necessitates continued innovation.
• Future research must address resistance mechanisms to improve long-term patient outcomes.
• Development of next-generation HER2 inhibitors is critical for overcoming therapeutic challenges.